Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07446881) titled 'A Phase 1 Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Advicenne Pharma
Condition:
EFFECT OF ADV7103 ON GASTRIC PH
Distal Renal Tublular Acidosis
Intervention:
Drug: ADV7103
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: February 25, 2025
Target Sample Size: 12
Countries of Recruitment:
France
To know more, visit https...